Ligand Pharmaceuticals Incorpor - stock earnings
LGND Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 18.2 million USD | 28.1 million USD |
| 2023Q3 | -12.8 million USD | 32.9 million USD |
| 2023Q2 | 2.3 million USD | 26.4 million USD |
| 2023Q1 | 41.9 million USD | 44.0 million USD |
| 2022Q4 | -14.5 million USD | 50.4 million USD |
| 2022Q3 | 404000 USD | 66.1 million USD |
| 2022Q2 | -895000 USD | 57.4 million USD |
| 2022Q1 | -15.4 million USD | 45.7 million USD |
| 2021Q4 | -5.0 million USD | 72.5 million USD |
| 2021Q3 | 13.7 million USD | 64.8 million USD |
| 2021Q2 | 30.7 million USD | 84.7 million USD |
| 2021Q1 | 18.1 million USD | 55.2 million USD |
| 2020Q4 | 5.8 million USD | 70.0 million USD |
| 2020Q3 | -6.7 million USD | 41.8 million USD |
| 2020Q2 | 22.1 million USD | 41.4 million USD |
| 2020Q1 | -24.1 million USD | 33.2 million USD |
| 2019Q4 | -7.4 million USD | 27.0 million USD |
| 2019Q3 | -15.3 million USD | 24.8 million USD |
| 2019Q2 | -14.4 million USD | 25.0 million USD |
| 2019Q1 | 666.3 million USD | 43.5 million USD |
| 2018Q4 | -42.5 million USD | 59.6 million USD |
| 2018Q3 | 67.4 million USD | 45.7 million USD |
| 2018Q2 | 73.2 million USD | 90.0 million USD |
| 2018Q1 | 45.3 million USD | 56.2 million USD |
| 2017Q4 | -7.0 million USD | 50.5 million USD |
| 2017Q3 | 8.4 million USD | 33.4 million USD |
| 2017Q2 | 6.1 million USD | 28.0 million USD |
| 2017Q1 | 5.1 million USD | 29.3 million USD |
| 2016Q4 | -3.1 million USD | 38.2 million USD |
| 2016Q3 | 644000 USD | 21.6 million USD |
| 2016Q2 | -5.8 million USD | 19.5 million USD |
| 2016Q1 | 6.6 million USD | 29.6 million USD |
| 2015Q4 | 6.3 million USD | 21.2 million USD |
| 2015Q3 | 224.5 million USD | 17.7 million USD |
| 2015Q2 | 23.6 million USD | 18.4 million USD |
| 2015Q1 | 754000 USD | 14.6 million USD |
| 2014Q4 | 7.1 million USD | 23.0 million USD |
| 2014Q3 | 1.3 million USD | 15.0 million USD |
| 2014Q2 | 1.6 million USD | 10.6 million USD |
| 2014Q1 | 2.1 million USD | 16.0 million USD |
| 2013Q4 | 1.9 million USD | 14.7 million USD |
| 2013Q3 | 2.0 million USD | 13.0 million USD |
| 2013Q2 | 6.1 million USD | 9.6 million USD |
| 2013Q1 | 1.5 million USD | 11.7 million USD |
| 2012Q4 | 1.1 million USD | 13.6 million USD |
| 2012Q3 | -194000 USD | 6.4 million USD |
| 2012Q2 | -2.3 million USD | 5.7 million USD |
| 2012Q1 | 1.4 million USD | 5.6 million USD |
| 2011Q4 | 5.5 million USD | 12.9 million USD |
| 2011Q3 | -3.9 million USD | 5.7 million USD |
| 2011Q2 | -914000 USD | 7.5 million USD |
| 2011Q1 | 9.5 million USD | 3.9 million USD |
| 2010Q4 | 4.5 million USD | 3.9 million USD |
| 2010Q3 | -11.8 million USD | 7.8 million USD |
| 2010Q2 | -283000 USD | 5.8 million USD |
| 2010Q1 | -2.8 million USD | 6.0 million USD |
| 2009Q4 | 3.0 million USD | 14.0 million USD |
| 2009Q3 | 1.8 million USD | 7.9 million USD |
| 2009Q2 | -1.7 million USD | 7.6 million USD |
| 2009Q1 | -5.1 million USD | 9.5 million USD |
| 2008Q4 | -69.6 million USD | 12.4 million USD |
| 2008Q3 | -18.1 million USD | 5.2 million USD |
| 2008Q2 | -6.4 million USD | 4.8 million USD |
| 2008Q1 | -3.9 million USD | 4.9 million USD |
| 2007Q4 | 5.9 million USD | 5.8 million USD |
| 2007Q3 | 1.2 million USD | 5.5 million USD |
| 2007Q2 | 181000 USD | 1.4 million USD |
| 2007Q1 | 274.3 million USD | 235000 USD |
| 2006Q4 | 141.4 million USD | 34.1 million USD |
| 2006Q3 | -14.9 million USD | 36.7 million USD |
| 2006Q2 | -16.0 million USD | 48.4 million USD |
| 2006Q1 | -142.2 million USD | 51.0 million USD |
| 2005Q4 | -2.7 million USD | 49.1 million USD |
| 2005Q3 | -11.0 million USD | 36.9 million USD |
| 2005Q2 | -8.9 million USD | 45.8 million USD |
| 2005Q1 | -18.5 million USD | 37.0 million USD |
| 2004Q4 | -11.0 million USD | 36.9 million USD |
| 2004Q3 | -6.8 million USD | 49.5 million USD |
| 2004Q2 | -14.2 million USD | 40.5 million USD |
| 2004Q1 | -13.1 million USD | 36.6 million USD |
| 2003Q4 | 5.9 million USD | 57.6 million USD |
| 2003Q3 | -11.1 million USD | 31.3 million USD |
| 2003Q2 | -12.0 million USD | 29.1 million USD |
| 2003Q1 | -20.3 million USD | 23.1 million USD |
| 2002Q4 | -6.7 million USD | 27.3 million USD |
| 2002Q3 | -7.0 million USD | 25.3 million USD |
| 2002Q2 | -12.2 million USD | 19.2 million USD |
| 2002Q1 | -6.6 million USD | 24.9 million USD |
| 2001Q4 | -13.1 million USD | 22.6 million USD |
| 2001Q3 | -7.7 million USD | 19.2 million USD |
| 2001Q2 | -10.6 million USD | 17.5 million USD |
| 2001Q1 | -11.6 million USD | 17.0 million USD |
| 2000Q4 | -26.0 million USD | 13.6 million USD |
| 2000Q3 | -14.9 million USD | 12.1 million USD |
| 2000Q2 | -16.5 million USD | 10.8 million USD |
| 2000Q1 | -15.0 million USD | 11.7 million USD |
| 1999Q4 | -22.8 million USD | 12.4 million USD |
| 1999Q3 | -18.3 million USD | 9.8 million USD |
| 1999Q2 | -19.0 million USD | 8.4 million USD |
| 1999Q1 | -14.6 million USD | 10.3 million USD |
| 1998Q4 | -40.7 million USD | 4.3 million USD |
| 1998Q3 | -46.3 million USD | 3.9 million USD |
| 1998Q2 | -17.4 million USD | 4.4 million USD |
| 1998Q1 | -13.5 million USD | 5.1 million USD |
| 1997Q4 | -68.1 million USD | 21.8 million USD |
| 1997Q3 | -11.6 million USD | 10.2 million USD |
| 1997Q2 | -10.4 million USD | 9.9 million USD |
| 1997Q1 | -10.1 million USD | 9.8 million USD |
| 1996Q4 | -11.8 million USD | 9.6 million USD |
| 1996Q3 | -8.4 million USD | 10.1 million USD |
| 1996Q2 | -10.0 million USD | 8.5 million USD |
| 1996Q1 | -7.1 million USD | 8.8 million USD |
| 1995Q4 | -8.4 million USD | 7.9 million USD |
| 1995Q3 | -8.5 million USD | 6.6 million USD |
| 1995Q2 | -41.5 million USD | 5.4 million USD |
| 1995Q1 | -5.8 million USD | 4.6 million USD |
| 1994Q4 | -6.5 million USD | 4.8 million USD |
| 1994Q3 | -6.3 million USD | 3.7 million USD |
| 1994Q2 | -7.4 million USD | 2.5 million USD |
| 1994Q1 | -6.9 million USD | 2.3 million USD |
LGND Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 52.2 million USD | 131.3 million USD |
| 2022 | -5.2 million USD | 196.2 million USD |
| 2021 | 57.1 million USD | 277.1 million USD |
| 2020 | -3.0 million USD | 186.4 million USD |
| 2019 | 629.3 million USD | 120.3 million USD |
| 2018 | 143.3 million USD | 251.5 million USD |
| 2017 | 12.6 million USD | 141.1 million USD |
| 2016 | -1.6 million USD | 109.0 million USD |
| 2015 | 257.3 million USD | 71.9 million USD |
| 2014 | 12.0 million USD | 64.5 million USD |
| 2013 | 11.4 million USD | 49.0 million USD |
| 2012 | -527000 USD | 31.4 million USD |
| 2011 | 10.2 million USD | 30.0 million USD |
| 2010 | -12.5 million USD | 23.5 million USD |
| 2009 | -1.9 million USD | 38.9 million USD |
| 2008 | -98.1 million USD | 27.3 million USD |
| 2007 | 281.7 million USD | 12.9 million USD |
| 2006 | -31.7 million USD | 141.0 million USD |
| 2005 | -45.1 million USD | 163.5 million USD |
| 2004 | -45.1 million USD | 163.5 million USD |
| 2003 | -37.5 million USD | 141.1 million USD |
| 2002 | -32.6 million USD | 96.6 million USD |
| 2001 | -43.0 million USD | 76.3 million USD |
| 2000 | -72.4 million USD | 48.1 million USD |
| 1999 | -74.7 million USD | 40.9 million USD |
| 1998 | -117.9 million USD | 17.7 million USD |
| 1997 | -100.2 million USD | 51.7 million USD |
| 1996 | -37.3 million USD | 36.8 million USD |
| 1995 | -64.2 million USD | 24.5 million USD |
| 1994 | -27.1 million USD | 13.3 million USD |
LGND
Price: $73.90
52 week price:
Earnings Per Share: 3.03 USD
P/E Ratio: 65.36
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Volume: 186100
Ebitda: 19.2 millionMarket Capitalization: 1.4 billion